Long-acting injectable antipsychotic treatment options for schizophrenia are part of the treatment plan but what are some of the barriers to their use? Professor John Kane and Dr Charlotte Emborg share their perspectives.
Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia
